Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Resuscitated sudden cardiac death in Andersen-Tawil syndrome.

Airey KJ, Etheridge SP, Tawil R, Tristani-Firouzi M.

Heart Rhythm. 2009 Dec;6(12):1814-7. doi: 10.1016/j.hrthm.2009.08.032. Epub 2009 Aug 29. No abstract available.

2.

Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.

Bökenkamp R, Wilde AA, Schalij MJ, Blom NA.

Heart Rhythm. 2007 Apr;4(4):508-11. Epub 2006 Dec 28. No abstract available.

PMID:
17399642
3.

Sudden cardiac death in Andersen-Tawil syndrome.

Peters S, Schulze-Bahr E, Etheridge SP, Tristani-Firouzi M.

Europace. 2007 Mar;9(3):162-6. Epub 2007 Feb 1.

4.

Andersen-Tawil syndrome associated with aborted sudden cardiac death: atrial pacing was effective for ventricular arrhythmias.

Kuramoto Y, Furukawa Y, Yamada T, Okuyama Y, Fukunami M.

Am J Med Sci. 2012 Sep;344(3):248-50. doi: 10.1097/MAJ.0b013e3182560209.

PMID:
22739561
5.

Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.

Fernlund E, Lundin C, Hertervig E, Kongstad O, Alders M, Platonov P.

Ann Noninvasive Electrocardiol. 2013 Sep;18(5):471-8. doi: 10.1111/anec.12074.

PMID:
24047492
6.

Imipramine for incessant ventricular arrhythmias in 2 unrelated patients with Andersen-Tawil syndrome.

Bigelow AM, Khalifa MM, Clark JM.

Heart Rhythm. 2015 Jul;12(7):1654-7. doi: 10.1016/j.hrthm.2015.03.032. Epub 2015 Mar 23. No abstract available.

PMID:
25814423
7.

Abnormal electroencephalogram, epileptic seizures, structural congenital heart disease and aborted sudden cardiac death in Andersen-Tawil syndrome.

Márquez MF, Totomoch-Serra A, Burgoa JA, Méndez A, Gómez-Flores JR, Nava S, Cardenas M.

Int J Cardiol. 2015 Feb 1;180:206-9. doi: 10.1016/j.ijcard.2014.11.157. Epub 2014 Nov 26. No abstract available.

PMID:
25463366
8.

Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.

Barajas-Martinez H, Hu D, Ontiveros G, Caceres G, Desai M, Burashnikov E, Scaglione J, Antzelevitch C.

Circ Cardiovasc Genet. 2011 Feb;4(1):51-7. doi: 10.1161/CIRCGENETICS.110.957696. Epub 2010 Dec 10.

9.

Electrophysiologic characteristics of an Andersen syndrome patient with KCNJ2 mutation.

Nagase S, Kusano KF, Yoshida M, Ohe T.

Heart Rhythm. 2007 Apr;4(4):512-5. Epub 2006 Nov 10.

PMID:
17399643
10.

Swimming-triggered aborted sudden cardiac death in a patient with Andersen-Tawil syndrome.

Efremidis M, Pappas LK, Sideris A, Letsas KP, Gavrielatos GD, Kardaras F.

Int J Cardiol. 2006 Sep 20;112(2):e45-7. Epub 2006 Jul 21.

PMID:
16859779
11.

Alternans of diastolic intracellular calcium elevation as the mechanism of bidirectional ventricular tachycardia in a rabbit model of Andersen-Tawil syndrome.

Maruyama M, Lin SF, Chen PS.

Heart Rhythm. 2012 Apr;9(4):626-7. doi: 10.1016/j.hrthm.2010.12.021. Epub 2010 Dec 15. No abstract available.

12.

The Twiddling Andersen.

Jefferies JL, Kim JJ, Belmont JW, Friedman RA.

Tex Heart Inst J. 2009;36(4):349-51.

13.

Combined inhibition of Na⁺ and Ca²⁺ channels: a novel paradigm for the treatment of incessant ventricular arrhythmias in Andersen-Tawil syndrome.

Janson CM, Poelzing S, Shah MJ.

Heart Rhythm. 2014 Feb;11(2):318-20. doi: 10.1016/j.hrthm.2013.11.003. Epub 2013 Nov 7. No abstract available.

PMID:
24211314
14.

Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome.

Pellizzón OA, Kalaizich L, Ptácek LJ, Tristani-Firouzi M, Gonzalez MD.

J Cardiovasc Electrophysiol. 2008 Jan;19(1):95-7. Epub 2007 Jul 27.

PMID:
17655675
15.

Andersen-Tawil syndrome: management challenges during pregnancy, labor, and delivery.

Subbiah RN, Gula LJ, Skanes AC, Krahn AD.

J Cardiovasc Electrophysiol. 2008 Sep;19(9):987-9. doi: 10.1111/j.1540-8167.2008.01216.x. Epub 2008 Jun 28.

PMID:
18554214
16.

Management and treatment of Andersen-Tawil syndrome (ATS).

Sansone V, Tawil R.

Neurotherapeutics. 2007 Apr;4(2):233-7. Review.

PMID:
17395133
17.

KCNJ2 variant of unknown significance reclassified as long QT syndrome causing ventricular fibrillation.

Obeyesekere MN, Klein GJ, Conacher S, Krahn AD.

Can J Cardiol. 2011 Nov-Dec;27(6):870.e11-3. doi: 10.1016/j.cjca.2011.05.004. Epub 2011 Aug 27.

PMID:
21875779
18.

[Aborted sudden death secondary to recurrent transient apical dyskinesia].

Gómez-Pérez A, Toquero-Ramos J, Fernández-Lozano I, Castro-Urda V.

Rev Esp Cardiol. 2006 Dec;59(12):1346-7. Spanish. No abstract available.

19.

Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome.

Sumitomo N, Shimizu W, Taniguchi K, Hiraoka M.

Heart Rhythm. 2008 Mar;5(3):498-9. doi: 10.1016/j.hrthm.2007.12.012. Epub 2007 Dec 23. No abstract available.

PMID:
18313615
20.

Andersen-Tawil syndrome: clinical and molecular aspects.

Nguyen HL, Pieper GH, Wilders R.

Int J Cardiol. 2013 Dec 5;170(1):1-16. Review.

PMID:
24383070
Items per page

Supplemental Content

Write to the Help Desk